Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Inhibrx Biosciences, Inc. INBX

Full chart Compare
Set alert

Price alert · INBX

All alert types
86.76 USD +5.68 (+7.01%)

At closeNov 4, 2026, 4:01 PM EST

86.76 0.00 0.00%

After hours · Nov 4, 4:01 PM ET

82.13 Day range 87.13
57.30 52-week range 155.29
YTD
+9.82%
1 year
+5.82%

Financial health

Altman Z-Score

-1.08 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -8.7×
FY 2016: -89.7×FY 2017: -30.3×FY 2018: -17.9×FY 2019: -14.6×FY 2020: -10.9×FY 2021: -20.3×FY 2022: -6.8×FY 2023: -7.4×FY 2024: 0.1×FY 2025: -8.7×
FY 2016 5y median -7.4× FY 2025
P/S 941×
FY 2016: 113×FY 2017: 70.8×FY 2018: 65.0×FY 2019: 82.9×FY 2020: 65.0×FY 2021: 233×FY 2022: 451×FY 2023: 995×FY 2024: 1115×FY 2025: 941×
FY 2016 5y median 941× FY 2025
P/B 153×
FY 2016: -81.6×FY 2017: -20.6×FY 2018: -9.7×FY 2019: -8.1×FY 2020: 11.0×FY 2021: 31.7×FY 2022: 17.0×FY 2023: 41.2×FY 2024: 1.7×FY 2025: 153×
FY 2016 5y median 31.7× FY 2025
P/FCF -9.4×
FY 2016: -41.2×FY 2017: -29.6×FY 2018: -22.8×FY 2019: -22.3×FY 2020: -16.9×FY 2021: -20.4×FY 2022: -8.5×FY 2023: -9.0×FY 2024: -1.1×FY 2025: -9.4×
FY 2016 5y median -9.0× FY 2025
EV/EBITDA -9.6×
FY 2016: -63.3×FY 2017: -30.8×FY 2018: -19.7×FY 2019: -19.7×FY 2020: -11.2×FY 2021: -21.2×FY 2022: -7.3×FY 2023: -8.3×FY 2024: 0.0×FY 2025: -9.6×
FY 2016 5y median -8.3× FY 2025
EV/Sales 928×
FY 2016: 113×FY 2017: 70.9×FY 2018: 65.9×FY 2019: 86.3×FY 2020: 57.9×FY 2021: 225×FY 2022: 420×FY 2023: 957×FY 2024: 392×FY 2025: 928×
FY 2016 5y median 420× FY 2025
FCF Yield -10.6%
FY 2016: -2.4%FY 2017: -3.4%FY 2018: -4.4%FY 2019: -4.5%FY 2020: -5.9%FY 2021: -4.9%FY 2022: -11.7%FY 2023: -11.1%FY 2024: -88.4%FY 2025: -10.6%
FY 2016 5y median -11.1% FY 2025

Profitability

Gross Margin -91.0%
FY 2016: -154.9%FY 2017: -204.0%FY 2018: -289.2%FY 2019: -426.9%FY 2020: 0.0%FY 2021: 62.3%FY 2022: -4926.7%FY 2023: 33.8%FY 2024: -1042.5%FY 2025: -91.0%
FY 2016 5y median -91.0% FY 2025
Operating Margin -10386.5%
FY 2016: -182.2%FY 2017: -235.1%FY 2018: -343.4%FY 2019: -450.4%FY 2020: -526.6%FY 2021: -1076.1%FY 2022: -5890.4%FY 2023: -12178.9%FY 2024: -165724.0%FY 2025: -10386.5%
FY 2016 5y median -10386.5% FY 2025
Net Margin -10773.5%
FY 2016: -124.0%FY 2017: -231.7%FY 2018: -362.6%FY 2019: -565.3%FY 2020: -594.3%FY 2021: -1147.6%FY 2022: -6625.3%FY 2023: -13408.9%FY 2024: 843786.0%FY 2025: -10773.5%
FY 2016 5y median -6625.3% FY 2025
ROE -1752.2%
FY 2016: 89.4%FY 2017: 67.6%FY 2018: 54.1%FY 2019: 54.9%FY 2020: -100.9%FY 2021: -156.1%FY 2022: -250.1%FY 2023: -554.8%FY 2024: 1263.3%FY 2025: -1752.2%
FY 2016 5y median -250.1% FY 2025
ROIC -117.4%
FY 2016: -38.5%FY 2017: -146.2%FY 2018: 11053.6%FY 2019: -386.8%FY 2020: -59.2%FY 2021: -59.1%FY 2022: -48.7%FY 2023: -86.4%FY 2024: -234.0%FY 2025: -117.4%
FY 2016 5y median -86.4% FY 2025
ROA -95.6%
FY 2016: -38.9%FY 2017: -112.7%FY 2018: -312.1%FY 2019: -194.0%FY 2020: -53.0%FY 2021: -54.3%FY 2022: -49.9%FY 2023: -78.4%FY 2024: 933.6%FY 2025: -95.6%
FY 2016 5y median -54.3% FY 2025

Growth (YoY)

Revenue 550.0%
FY 2016: 0.0%FY 2017: 25.9%FY 2018: 2.4%FY 2019: 5.8%FY 2020: 40.9%FY 2021: -44.4%FY 2022: -69.2%FY 2023: -17.9%FY 2024: -88.9%FY 2025: 550.0%
FY 2016 FY 2025
Operating Income 59.3%
FY 2016: 0.0%FY 2017: -62.4%FY 2018: -49.6%FY 2019: -38.8%FY 2020: -64.7%FY 2021: -13.7%FY 2022: -68.4%FY 2023: -69.8%FY 2024: -51.2%FY 2025: 59.3%
FY 2016 FY 2025
EPS (diluted) -107.8%
FY 2016: 0.0%FY 2017: -195.7%FY 2018: -69.1%FY 2019: -22.6%FY 2020: 100.0%FY 2021: 0.0%FY 2022: -68.4%FY 2023: -41.4%FY 2024: 2377.0%FY 2025: -107.8%
FY 2016 FY 2025
Free Cash Flow 34.1%
FY 2016: 0.0%FY 2017: -9.7%FY 2018: -22.0%FY 2019: -38.2%FY 2020: -45.6%FY 2021: -64.6%FY 2022: -42.9%FY 2023: -70.6%FY 2024: 0.5%FY 2025: 34.1%
FY 2016 FY 2025

Financial Health

Current Ratio 3.9×
FY 2016: 3.9×FY 2017: 1.7×FY 2018: 0.3×FY 2019: 0.8×FY 2020: 4.2×FY 2021: 6.2×FY 2022: 10.2×FY 2023: 5.2×FY 2024: 3.9×FY 2025: 3.9×
FY 2016 5y median 5.2× FY 2025
Quick Ratio 3.9×
FY 2016: 3.9×FY 2017: 1.6×FY 2018: 0.2×FY 2019: 0.6×FY 2020: 8.3×FY 2021: 6.2×FY 2022: 10.2×FY 2023: 5.2×FY 2024: 3.9×FY 2025: 3.9×
FY 2016 5y median 5.2× FY 2025
Debt / Equity 13.4×
FY 2016: -2.0×FY 2017: -0.5×FY 2018: -0.2×FY 2019: -0.4×FY 2020: 0.5×FY 2021: 1.4×FY 2022: 3.6×FY 2023: 4.8×FY 2024: 0.1×FY 2025: 13.4×
FY 2016 5y median 3.6× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 0.1×FY 2017: -0.1×FY 2018: -0.3×FY 2019: -0.8×FY 2020: 1.4×FY 2021: 0.8×FY 2022: 0.5×FY 2023: 0.3×FY 2024: -0.1×FY 2025: 0.1×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -11.1×
FY 2016: 0.0×FY 2017: -9.3×FY 2018: -19.9×FY 2019: -7.2×FY 2020: -6.2×FY 2021: -14.7×FY 2022: -8.0×FY 2023: -6.9×FY 2024: -24.6×FY 2025: -11.1×
FY 2016 5y median -11.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.2%FY 2018: 0.1%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 5.5%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -7.1%FY 2018: -2.7%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.7%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31